novo nordisk semaglutide patent Expiry Day: India MD On How Company Plans To Defend Its Dominance Natco beats rivals with Rs

The compounded GLP-1 medications it connects patients with - semaglutide starting at $199/month and tirzepatide starting at $349/month - are priced well below FDA-approved branded alternatives, with the tradeoffs that compounded medications carry: no FDA premarket review as finished products, and an active regulatory environment that could change their availability

Patient Experiences and Case Studies 7

Heres what you need to know: Manufacturer Savings Programs Novo Nordisk (makes Wegovy, Ozempic, and Saxenda) offers savings cards that can reduce copays to as low as $25 per month for eligible patients with commercial insurance These programs have specific eligibility requirements and typically exclude Medicare/Medicaid patients Your doctors office can help you determine eligibility and apply Prior Authorization Tips If your insurance requires prior authorization, be patient

4 patients (0.2 cases per 100 patient-years) receiving placebo